Publications

Detailed Information

Chemical inhibitors destabilize HuR binding to the AU-rich element of TNF-alpha mRNA

DC Field Value Language
dc.contributor.authorChae, Min-Ju-
dc.contributor.authorSung, Hye Youn-
dc.contributor.authorKim, Eun-Hye-
dc.contributor.authorLee, Mira-
dc.contributor.authorChae, Chong Hak-
dc.contributor.authorPark, Woong-Yang-
dc.contributor.authorKim, Sunwoo-
dc.contributor.authorKwak, Hojoong-
dc.date.accessioned2012-07-03T02:22:18Z-
dc.date.available2012-07-03T02:22:18Z-
dc.date.issued2009-11-30-
dc.identifier.citationEXPERIMENTAL AND MOLECULAR MEDICINE; Vol.41 11; 824-831ko_KR
dc.identifier.issn1226-3613-
dc.identifier.urihttps://hdl.handle.net/10371/78194-
dc.description.abstractHu protein R (HuR) binds to the AU-rich element (ARE) in the 3`UTR to stabilize TNF-alpha mRNA. Here, we identified chemical inhibitors of the interaction between HuR and the ARE of TNF-alpha mRNA using RNA electrophoretic mobility gel shift assay (EMSA) and filter binding assay. Of 179 chemicals screened, we identified three with a half-maximal inhibitory concentration (IC(50)) below 10 mu M. The IC(50) of quercetin, b-40, and b-41 were 1.4, 0.38, and 6.21 mu M, respectively, for binding of HuR protein to TNF-alpha mRNA. Quercetin and b-40 did not inhibit binding of tristetraprolin to the ARE of TNF-alpha mRNA. When LPS-treated RAW264.7 cells were treated with quercetin and b-40, we observed decreased stability of TNF-alpha mRNA and decreased levels of secreted TNF-alpha. From these results, we could find inhibitors for the TNF-alpha mRNA stability, which might be used advantageously for both the study for post-transcriptional regulation and the discovery of new anti-inflammation drugs.ko_KR
dc.description.sponsorshipThis work was supported by a grant
from the Ministry of Education, Science and Technology,
Korea (M20706000020-07M0600-02010, W.Y.P.), the BK21
program (W.Y.P.), and Seoul National University Hospital
(W.Y.P.).
ko_KR
dc.language.isoenko_KR
dc.publisherKOREAN SOC MED BIOCHEMISTRY MOLECULAR BIOLOGYko_KR
dc.subjectanti-inflammatory agentsko_KR
dc.subjectELAV-Iike protein 1ko_KR
dc.subjectlipopolysaccharidesko_KR
dc.subjecttumor necrosis factor-alphako_KR
dc.subjectquercetinko_KR
dc.subjectmacrophagesko_KR
dc.titleChemical inhibitors destabilize HuR binding to the AU-rich element of TNF-alpha mRNAko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor채민주-
dc.contributor.AlternativeAuthor성혜윤-
dc.contributor.AlternativeAuthor김은혜-
dc.contributor.AlternativeAuthor이미라-
dc.contributor.AlternativeAuthor곽호중-
dc.contributor.AlternativeAuthor채총학-
dc.contributor.AlternativeAuthor김선우-
dc.contributor.AlternativeAuthor박웅양-
dc.identifier.doi10.3858/emm.2009.41.11.088-
dc.citation.journaltitleEXPERIMENTAL AND MOLECULAR MEDICINE-
dc.description.citedreferenceKwak H, 2009, BMB REP, V42, P41-
dc.description.citedreferenceGrattendick KJ, 2008, INT IMMUNOPHARMACOL, V8, P679, DOI 10.1016/j.intimp.2008.01.013-
dc.description.citedreferenceMeisner NC, 2007, NAT CHEM BIOL, V3, P508, DOI 10.1038/nchembio.2007.14-
dc.description.citedreferenceSeko Y, 2006, AUTOIMMUN REV, V5, P299, DOI 10.1016/j.autrev.2005.10.013-
dc.description.citedreferenceJung KC, 2006, LEUKEMIA, V20, P122, DOI 10.1038/sj.leu.2404022-
dc.description.citedreferenceFan J, 2005, EUR RESPIR J, V26, P933, DOI 10.1183/09031936.05.00120204-
dc.description.citedreferenceMcMullen MR, 2003, J BIOL CHEM, V278, P38333, DOI 10.1074/jbc.M304566200-
dc.description.citedreferenceKumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177-
dc.description.citedreferenceMazan-Mamczarz K, 2003, P NATL ACAD SCI USA, V100, P8354, DOI 10.1073/pnas.1432104100-
dc.description.citedreferenceZhang T, 2002, BIOCHEM SOC T, V30, P952-
dc.description.citedreferenceHollams EM, 2002, NEUROCHEM RES, V27, P957, DOI 10.1023/A:1020992418511-
dc.description.citedreferenceKang MJ, 2002, BIOCHEM BIOPH RES CO, V293, P617, DOI 10.1016/S0006-291X(02)00264-4-
dc.description.citedreferenceDean JLE, 2001, MOL CELL BIOL, V21, P721, DOI 10.1128/MCB.21.3.721-730.2001-
dc.description.citedreferenceBrennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854-
dc.description.citedreferenceWang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000-
dc.description.citedreferenceLai WS, 1999, MOL CELL BIOL, V19, P4311-
dc.description.citedreferenceFan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448-
dc.description.citedreferenceLevy NS, 1998, J BIOL CHEM, V273, P6417, DOI 10.1074/jbc.273.11.6417-
dc.description.citedreferenceMa WJ, 1996, J BIOL CHEM, V271, P8144-
dc.description.citedreferenceBEUTLER B, 1989, ANNU REV IMMUNOL, V7, P625, DOI 10.1146/annurev.iy.07.040189.003205-
dc.description.tc8-
Appears in Collections:
Files in This Item:

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share